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1 First three authors are considered as co-ﬁrst authoMicroRNAs are approximately 22nt non-coding RNAs that are present in a broad range of multicel-
lular organisms. MicroRNAs play important roles in many biological or pathological processes by
regulating the expression of their target genes. The fast and accurate identiﬁcation of miRNA targets
is a bottleneck in the clariﬁcation of the function of miRNAs. Here, we established a rapid and accu-
rate strategy to identify miRNA functional target genes by combination of bioinformatic prediction
with Cytoplasmic/Nuclear (C/N) ratios of mRNAs. The strategy comprises three steps: bioinformatic
prediction, determination of mRNA C/N ratios, and conﬁrmation by Western blotting, and might be
suitable to most miRNAs. Our method will make a signiﬁcant contribution to the study of the bio-
logical functions of miRNAs.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
MicroRNAs are approximately 22 nt non-coding RNAs that exist
in a broad range of multicellular organisms. The primary miRNA
transcripts (pri-miRNAs) are transcribed by RNA polymerase II,
cleaved by Drosha/Pasha to form approximate 70 nt stem-loop
pre-miRNAs in the nucleus, and then exported into cytoplasm by
exportin-5, where they are subsequently processed by Dicer to
generate mature miRNAs [1,2]. The mature miRNAs associate with
Argonaute proteins to form the RNA-induced silencing complex
(RISC) [3], which then induces the decay of target mRNAs or inhi-
bition of translation. Recent research showed that miRNAs play
important roles in many processes, such as cell proliferation, apop-
tosis, differentiation, metabolism, development, and tumor metas-
tasis, by regulating their target gene expression [4–6].
Several hundred miRNAs have been identiﬁed, but few func-
tions of miRNAs have been fully elucidated, largely because only
rare miRNA targets were conﬁrmed. As more than one third of hu-
man genes have been predicted to contain conserved miRNA tar-
gets, the fast and accurate identiﬁcation of miRNA targets is of
great importance in the clariﬁcation of the function of miRNAs.
Due to their short length and non-perfect complementarity withchemical Societies. Published by E
rs.their targets, the conﬁrmation of miRNA targets has been extraor-
dinarily complicated.
With the development of bioinformatics, a variety of important
rules, models, and algorithms have been used to predict miRNA
targets by computational analyses. To date, more than 10 software
programs for the prediction of miRNA targets have been developed
since the ﬁrst bioinformatic software, miRanda, was designed in
2003 [7,8]. Undoubtedly, computational analyses facilitate miRNA
target prediction to a great extent; however, the results from the
bioinformatics often generate several or hundred potential targets
for one miRNA. It is not possible to assess the accuracy of these
predictions without a quick, easy, and reliable method. Therefore,
many groups have attempted to develop experimental methods
to identify miRNA target genes. One strategy to search for miRNA
target genes is to transfect the mature miRNA duplex (or its inhib-
itors) into cells to overexpress or knock down the miRNA, and then
examine changes in the mRNA proﬁle by microarrays to ﬁnd corre-
sponding miRNA target genes [9,10]. Another strategy is to use a
co-immunoprecipitation assay to isolate miRNA target mRNAs
based on the observation that the Ago proteins or miRNPs can bind
both miRNAs and mRNAs [11,12]. Recently, two groups created a
new strategy to search for miRNA target genes by a proteomics-
related approach based on altered protein levels [13,14]. Though
these experimental approaches are effective supports for bioinfor-
matic predictions, they are neither quick, easy, nor sufﬁciently
high-throughput for searching for miRNA target genes.lsevier B.V. All rights reserved.
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the nucleus (C/N ratios) were closely related to the corresponding
miRNA targets, and we hypothesized that a rapid strategy might be
established to identify miRNA target genes by a combination of
bioinformatic prediction and the mRNA C/N ratios of potential
miRNA target genes.
2. Materials and methods
2.1. Transfection
All miRNA mimics were obtained from GenePharma and miRNA
inhibitor were got from TaKaRa. All transfections were carried out
using lipofectamine 2000 according to the manufacturer’s protocol
(Invitrogen). HeLa and HepG2 cells (80% conﬂuent) were transfec-
ted in 24-well plates.
2.2. RNA isolation
Nuclear and Cytoplasmic RNAs of HeLa and HepG2 cells were
obtained separately using Cytoplasmic and Nuclear RNA Puriﬁca-
tion Kits (Norgen).
2.3. HOA gene expression microarray analysis
The purities of the RNA samples were veriﬁed using the absor-
bance ratio (1.87–2.2) at 260 nm/280 nm by a NanoDrop ND-1000
(NanoDrop), and by RNA integrity number (RIN) score of above 7 as
determined by an Agilent RNA 6000 Nano Assay (Agilent). There
was no DNA contamination when checked by agarose gel electro-
phoresis. Aminoallyl-RNA (aRNA) probes were ampliﬁed using
the MessageAmp aRNA kit (Ambion, cat# 1753) and labeled with
the NHS-Cy5 (GE Amersham, USA, cat# PA25001). The Cy5-labeled
aRNA probes were further puriﬁed and quantiﬁed. The labeled
probes were hybridized at 50 C for 16 h to the HumanWhole Gen-
ome OneArray™ Version 4.3 (PhalanxBiotech Group, Taiwan) con-
taining 30 968 well-characterized genes. After sample washing
steps, the array was scanned using an Axon 4000B Scanner (Molec-
ular Devices, USA) and analyzed with Genepix software (Molecular
Devices USA).
2.4. Real-time quantitative polymerase chain reaction (QPCR)
Relative mRNA levels were determined via quantitative PCR
using a Stratagene MX3000P system, SYBR

Premix Ex Taq™
(TaKaRa), and speciﬁc primers (listed in Table S1). The CT values
were determined via the MX3000p software (version 4.10) using
the ampliﬁcation-based threshold determination and adaptive
baseline analysis options. Primer sequences used in this study:GAPDH: forward 50-GAAGGTGAAGGTCGGAGTC-30 reverse
50-GAAGATGGTGATGGGATTTC-30;
E2F1: forward 50-CACAGATCCCAGCCAGTCTCTA-30 reverse
50-GAGAAGTCCTCCCGCACATG-30;
RB1: forward 50-GGAAGCAACCCTCCTAAACC-30 reverse
50-TTTCTGCTTTTGCATTCGTG-30;
RBL1: forward 50-AGAATGCCTCCTGGACCTTT-30 reverse
50-GGGGTGTCACGAGTGAACTT-30;
RBL2: forward 50-ATTTGGCATGGAAACCAGAG-30 reverse
50-GTCACCCTTCTGGGAGTCAA-30;
MXD1: forward 50-CTGGAGGTACCCATTCCAGA-30 reverse
50-TGTTGCTCAGGCAGATTTTG-30;
P21: forward 50-ATGAAATTCACCCCCTTTCC-30 reverse
50-CCCTAGGCTGTGCTCACTTC-30.
EGR2: forward 50-GAACGGAGTGGCGGGAGATG-30 reverse
50-ACTGTGGGTCAATGGAGAATTTGC-302.5. Cell lysis and immunoblotting
Cells were washed with PBS (25 C) and then lysed over 20 min
in cold lysis buffer (50 mM Tris–HCl; pH 7.4; 1% NP-40; 0.25% so-
dium deoxycholate; 150 mM NaCl; 1 mM each EDTA, PMSF,
Na3VO4, and NaF; 1 lg/ml each aprotinin, leupeptin, and pepsta-
tin). Extracts were clariﬁed by centrifugation (10,000g) for
20 min at 4 C. Protein concentrations were determined by the
Bradford assay. Proteins were separated using 10% SDS–PAGE
and transferred to a nitrocellulose membrane. The membrane
was blocked in a solution of TBS containing 5% nonfat dry milk
and 0.05% Tween-20 (TBST-MILK) for 30 min at 25 C with constant
agitation, incubated with primary antibodies (following the manu-
facturer’s instructions) for 2 h at 25 C, washed with TBST, and
incubated for 1 h with a goat anti-rabbit HRP-conjugated IgG
(1:5000 dilution). After three additional washes, enhanced chemi-
luminescence (ECL) was performed according to manufacturer’s
protocol (GE Healthcare). The polyclonal antibodies for E2F1,
RB1, P21, MXD1, RBL1, RBL2, and EGR2 were all purchased from
Bioworld Technology. The polyclonal antibodies for MSN, WASF3,
ZEB1, TFAP2A, SFRS1, and CDYL were all purchased from AVIVA
Systems Biology. The Tubulin and Actin (controls) polyclonal anti-
bodies were obtained from Santa Cruz.
3. Results and discussion
3.1. Determining the mRNA C/N ratios of miR-93 potential target genes
in HeLa and HepG2 cells
Several lines of evidence showed that the target genes of miRNA
might be numerous and closely related to cell types [15,16]; there-
fore, we speculated that the authentic targets of one miRNA in one
cell line should be its ‘‘functional targets” and might be variable in
another cell line. Only the functional targets of miRNAs have dom-
inant biological functions.
To verify our hypothesis, hsa-miR-93 was chosen and its target
genes were identiﬁed separately in HeLa and HepG2 cells. Firstly,
we used bioinformatic software TargetScan [17] to predict the po-
tential target genes of miR-93. Among all the predicted potential
target genes, seven genes (E2F1, RB1, EGR2, MXD1, RBL2, RBL1,
and P21) were randomly chosen that aligned with the total context
score shown in Table 1.
We then used an mRNA microarray to investigate the mRNA C/
N ratios of the above genes in HeLa and HepG2 cells. The results
showed that the mRNA C/N ratios of these genes were different
in the two cell lines (Table 2).
To eliminate possible errors caused by the microarrays (usually
the normalized intensity was less than 100), we further conﬁrmed
the mRNA C/N ratios of these genes by ﬂuorescent quantitative
PCR. As shown in Fig. 1, the mRNA C/N ratios of these genes ob-
tained by the microarray were in accord with those obtained by
QPCR. Genes with high mRNA C/N ratios may be the functional tar-
gets of miR-93.Table 1
Predicted targets of hsa-miR-93.
miRNA Gene symbol Score*
Hsa-miR-93 E2F1 0.30
RB1 0.18
EGR2 0.34
MXD1 0.21
RBL2 0.45
RBL1 0.50
P21 0.36
* Total context score in TargetScan.
Table 2
Microarray results of the nuclear and cytoplasmic RNA levels of predicted miR-93 targets in both HeLa and HepG2 cells.
miRNA Gene symbol Normalized intensity Ratio (fold change)
HeLa
cytosol
HeLa
nucleus
HepG2
cytosol
HepG2
nucleus
HeLa
C/N
HepG2
C/N
Hsa-miR-93 E2F1 1065.8499 1203.5016 1058.1867 768.19054 0.885624 1.377505
RB1 984.34298 1041.0243 565.59986 748.79439 0.945552 0.755347
P21 1348.3671 744.48716 1254.6703 626.09278 1.811135 2.003969
MXD1 444.26463 606.02619 275.16028 334.76852 0.733078 0.821942
RBL1 783.34176 654.0402 444.89353 589.08476 1.197697 0.755228
RBL2 420.94336 380.08914 364.04264 337.26269 1.107486 1.079404
EGR2 217.08274 78.274302 421.82059 137.29771 2.773359 3.072306
Fig. 1. QPCR validation of microarray results of the cytoplasmic and nuclear mRNA levels of predicted miR-93 targets.
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seven potential target genes into three groups: lower C/N ratios
(<1) both in HeLa and HepG2 cells, (RB1 and MXD1); higher C/N
ratios (>1) both in HeLa and HepG2 cells (EGR2, P21, and RBL2);and differential C/N ratios in HeLa and HepG2 cells (E2F1 and
RBL1).
Based on the above C/N ratios, we speculated that RBL1 might
be the functional target of miR-93 in HeLa cells, not E2F1. E2F1
Fig. 2. Validation mir-93 targets byWestern blotting. (A) Western blotting results showing that P21, RBL2, and EGR2 are functional targets of mir-93, both in HeLa and HepG2
cells when transfected with miR-93 mimics, but that RB1 and MXD1 are not targets of mir-93. (B) Validation of RBL1 and E2F1 as targets of miR-93 in HeLa and HepG2 cells
when transfected with miR-93 mimics. (C) Western blotting validation mir-93 targets via speciﬁc inhibitors.
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RBL1. EGR2, P21, and RBL2 might all be the functional targets of
miR-93 both in HeLa and HepG2 cells. We also speculated that
RB1 and MXD1 might not be the functional targets of miR-93 in
HeLa or in HepG2 cells.
To testify our deductions, Western blotting was performed to
directly detect the proteins encoded by these genes after transfec-
tion of miR-93 mimics into HeLa and HepG2 cells, respectively. The
results showed that EGR2, P21, and RBL2 were all the functional
targets of miR-93 both in HeLa and HepG2 cells. RB1 and MXD1
were not functional targets of miR-93 in either cell line (Fig. 2A).
Interestingly, we also conﬁrmed that RBL1 was the functional tar-
get of has-miR-93 only in HeLa cells and that E2F1 was the func-
tional target of has-miR-93 only in HepG2 cells; i.e., the target of
the miRNA can be switched in different cell lines (Fig. 2B). Further-
more, we found that the miRNA speciﬁc inhibitors could inhibit the
effects of corresponding endogenous miRNAs in HeLa and HepG2
cells (Fig. 2C).
3.2. Further investigating the accuracy of the strategy by identifying
functional targets of miR-200b in Hela cells
To further investigate the accuracy of the strategy proposed in
this paper, we identiﬁed novel functional targets of miR-200b in
HeLa cells by a similar approach. Based on the bioinformatic pre-
diction and microarray results, we choose mRNAs with higher C/
N ratios (TFAP2A, SFRS1, and CDYL) and lower C/N ratios (MSN,
WASF3, and ZEB1) to determine whether these genes were the
functional targets of miR-200b in HeLa cells (Table 3). WesternTable 3
Microarray results of nuclear and cytoplasmic RNA levels of predicted miR-200b
targets in HeLa cells.
miRNA Gene
symbol
Normalized intensity Ratio
(fold change)
HeLa
cytosol
HeLa
nucleus
HeLa
C/N
Hsa-miR-200b MSN 1818.986 5207.509 0.349301
WASF3 6.442689 24.98957 0.257815
ZEB1 33.084355 124.77197 0.265159
TFAP2A 602.10825 334.88995 1.797929
SFRS1 5523.8152 2224.6729 2.482979
CDYL 420.94336 380.08914 1.684741blotting showed that TFAP2A, SFRS1, and CDYL were all indeed
functional targets of miR-200b in HeLa cells, but that MSN, WASF3,
and ZEB1 were not (Fig. 3).
Although ZEB1 was previously conﬁrmed as a target of miR-
200b in other cell lines [18,19], our results demonstrated that
ZEB1 was not a genuine functional target of miR-200b in HeLa
cells, which also conﬁrmed the concept of target switching of miR-
NAs. As most miRNAs usually bind to the 30 UTR of targeted
mRNAs, resulting in reduced translation but not affecting the levels
of the mRNAs, we suggest that the higher the levels of target
mRNAs in the cytoplasm of cells, the higher the possibility of them
being regulated by miRNAs, i.e., a dominant rule exists for miRNA
target mRNA interaction in cells. This could explain why genes
with high C/N ratios are functional targets and miRNA targets
can be switched in different cell lines. Our results conﬁrmed that
target switching of miRNAs exists in wild-type cells, whether this
phenomenon can be induced artiﬁcially, such as transfection of
extraneous genes into cells, needs to be investigated in the future
study.
3.3. The mRNA C/N ratios suitable for different miRNAs regulating the
same targets in the same cells lines
We choose another miRNAs potential targeting to E2F1 or RBL1
using TargetScan, that is miR-106 and miR-124 for RBL1, miR-106Fig. 3. Validation of mir-200b targets by Western blotting in HeLa cells. (A)
Validation of mir-200b targets via miR-200b mimics. (B) Validation of mir-200b
targets via miR-200b inhibitors.
Fig. 4. Validation different miRNAs effects on E2F1 and RBL1 in HeLa and HepG2
cells by Western blotting.
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that miR-106 and miR-124 indeed target the same gene (RBL1) as
miR-93 in HeLa cells, miR-106 and miR-205 target the same gene
(E2F1) as miR-93 in HepG2 cells (Fig. 4), which suggested that miR-
NAs regulating the same targets should have the same function in
the same cell lines.4. Conclusion
This is the ﬁrst report of an accurate and fast strategy to identify
miRNA functional target genes combining bioinformatic prediction
with C/N ratios of mRNAs. The strategy comprises three steps: bio-
informatic prediction, determination of C/N ratios and conﬁrma-
tion by Western blotting. Our method will make an important
contribution to the study of the biological functions of miRNAs.Acknowledgments
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